Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

LAMEA Clinical Trials Matching Software Market Size, Share & Industry Trends Analysis Report By Deployment Mode (Web & Cloud-based, and On-premises), By End-use, By Country and Growth Forecast, 2023 - 2030

Published Date : 30-Sep-2023

Pages: 104

Formats: PDF

The Latin America, Middle East and Africa Clinical Trials Matching Software Market would witness market growth of 16.6% CAGR during the forecast period (2023-2030).

The market is expected to grow due to increasing clinical trial complexity and the need for more efficient patient recruitment. Factors such as the growing volume of healthcare data and advances in AI technology are driving this growth. The adoption of clinical trial matching software face challenges related to data privacy, interoperability of healthcare systems, and regulatory compliance, especially with the implementation of laws like GDPR and HIPAA.

Many clinical trials matching software solutions must adhere to regulatory requirements, including patient privacy and data security. Compliance with regulations such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe is crucial. The rise of precision medicine has had a profound impact on the growing adoption of clinical trials matching software. Precision medicine, which tailors medical treatment and interventions to individual patient characteristics, including genetics, biomarkers, and clinical data, has ushered in a new era of targeted therapies and personalized healthcare.

As treatments become more specific and focused on particular patient subgroups, the need for precise patient-patient matching with clinical trials has become paramount. Clinical trials matching software plays a pivotal role in this context by efficiently and accurately identifying patients whose genetic or molecular profiles align with the eligibility criteria of specialized trials. This technology ensures that participants in precision medicine trials are not only more likely to benefit from the intervention but also contribute valuable data to the development of these groundbreaking therapies.

The need for clinical trials management software (CTMS) in Latin America is growing due to several factors that make the region an attractive destination for clinical research. CTMS solutions are vital in addressing the specific challenges and requirements of conducting clinical trials in Latin America. The region offers access to diverse patient populations across various ethnicities, genetic backgrounds, and disease demographics. This diversity is valuable for clinical trials that require representation from different groups. Latin American countries are modernizing their healthcare systems, including adopting electronic health records (EHRs) and telemedicine. CTMS solutions that integrate with these systems are increasingly relevant.

The Brazil market dominated the LAMEA Clinical Trials Matching Software Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,408.9 Thousands by 2030. The Argentina market is showcasing a CAGR of 17.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 16.3% during (2023 - 2030).

Based on Deployment Mode, the market is segmented into Web & Cloud-based, and On-premises. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, CROs, and Medical Device Firms. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Clinical Trials Matching Software Market is Projected to reach USD 362.7 Million by 2030, at a CAGR of 13.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Clario, IBM Corporation, Antidote Technologies, Inc., Ofni Systems Inc., Advarra, Inc., ArisGlobal LLC (Nordic Capital Limited), Teckro, Inc., BSI Business Systems Integration AG, Clinical Trials Mobile Application, Optimapharm d.o.o.

Scope of the Study

Market Segments Covered in the Report:

By Deployment Mode

  • Web & Cloud-based
  • On-premises

By End-use

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Medical Device Firms

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Clario
  • IBM Corporation
  • Antidote Technologies, Inc.
  • Ofni Systems Inc.
  • Advarra, Inc.
  • ArisGlobal LLC (Nordic Capital Limited)
  • Teckro, Inc.
  • BSI Business Systems Integration AG
  • Clinical Trials Mobile Application
  • Optimapharm d.o.o.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Clinical Trials Matching Software Market, by Deployment Mode
1.4.2 LAMEA Clinical Trials Matching Software Market, by End-use
1.4.3 LAMEA Clinical Trials Matching Software Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.1 Porter’s Five Force Analysis

Chapter 4. LAMEA Clinical Trials Matching Software Market, by Deployment Mode
4.1 LAMEA Web & Cloud-based Market, by Country
4.2 LAMEA On-premise Market, by Country

Chapter 5. LAMEA Clinical Trials Matching Software Market, by End-use
5.1 LAMEA Pharmaceutical & Biotechnology Companies Market, by Country
5.2 LAMEA CROs Market, by Country
5.3 LAMEA Medical Device Firms Market, by Country

Chapter 6. LAMEA Clinical Trials Matching Software Market, by Country
6.1 Brazil Clinical Trials Matching Software Market
6.1.1 Brazil Clinical Trials Matching Software Market, by Deployment Mode
6.1.2 Brazil Clinical Trials Matching Software Market, by End-use
6.2 Argentina Clinical Trials Matching Software Market
6.2.1 Argentina Clinical Trials Matching Software Market, by Deployment Mode
6.2.2 Argentina Clinical Trials Matching Software Market, by End-use
6.3 UAE Clinical Trials Matching Software Market
6.3.1 UAE Clinical Trials Matching Software Market, by Deployment Mode
6.3.2 UAE Clinical Trials Matching Software Market, by End-use
6.4 Saudi Arabia Clinical Trials Matching Software Market
6.4.1 Saudi Arabia Clinical Trials Matching Software Market, by Deployment Mode
6.4.2 Saudi Arabia Clinical Trials Matching Software Market, by End-use
6.5 South Africa Clinical Trials Matching Software Market
6.5.1 South Africa Clinical Trials Matching Software Market, by Deployment Mode
6.5.2 South Africa Clinical Trials Matching Software Market, by End-use
6.6 Nigeria Clinical Trials Matching Software Market
6.6.1 Nigeria Clinical Trials Matching Software Market, by Deployment Mode
6.6.2 Nigeria Clinical Trials Matching Software Market, by End-use
6.7 Rest of LAMEA Clinical Trials Matching Software Market
6.7.1 Rest of LAMEA Clinical Trials Matching Software Market, by Deployment Mode
6.7.2 Rest of LAMEA Clinical Trials Matching Software Market, by End-use

Chapter 7. Company Profiles
7.1 Clario
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Partnerships, Collaborations, and Agreements:
7.1.3 SWOT Analysis
7.2 IBM Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Antidote Technologies, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.3.3 SWOT Analysis
7.4 Ofni Systems Inc.
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Advarra, Inc.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 ArisGlobal LLC (Nordic Capital Limited)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Geographical Expansions:
7.6.3 SWOT Analysis
7.7 Teckro, Inc.
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 BSI Business Systems Integration AG
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Clinical Trials Mobile Application
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Optimapharm d.o.o.
7.10.1 Company Overview
7.10.2 SWOT Analysis
TABLE 1 LAMEA Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 2 LAMEA Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 3 LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 4 LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 5 LAMEA Web & Cloud-based Market, by Country, 2019 - 2022, USD Thousands
TABLE 6 LAMEA Web & Cloud-based Market, by Country, 2023 - 2030, USD Thousands
TABLE 7 LAMEA On-premise Market, by Country, 2019 - 2022, USD Thousands
TABLE 8 LAMEA On-premise Market, by Country, 2023 - 2030, USD Thousands
TABLE 9 LAMEA Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 10 LAMEA Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 11 LAMEA Pharmaceutical & Biotechnology Companies Market, by Country, 2019 - 2022, USD Thousands
TABLE 12 LAMEA Pharmaceutical & Biotechnology Companies Market, by Country, 2023 - 2030, USD Thousands
TABLE 13 LAMEA CROs Market, by Country, 2019 - 2022, USD Thousands
TABLE 14 LAMEA CROs Market, by Country, 2023 - 2030, USD Thousands
TABLE 15 LAMEA Medical Device Firms Market, by Country, 2019 - 2022, USD Thousands
TABLE 16 LAMEA Medical Device Firms Market, by Country, 2023 - 2030, USD Thousands
TABLE 17 LAMEA Clinical Trials Matching Software Market, by Country, 2019 - 2022, USD Thousands
TABLE 18 LAMEA Clinical Trials Matching Software Market, by Country, 2023 - 2030, USD Thousands
TABLE 19 Brazil Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 20 Brazil Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 21 Brazil Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 22 Brazil Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 23 Brazil Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 24 Brazil Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 25 Argentina Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 26 Argentina Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 27 Argentina Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 28 Argentina Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 29 Argentina Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 30 Argentina Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 31 UAE Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 32 UAE Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 33 UAE Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 34 UAE Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 35 UAE Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 36 UAE Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 37 Saudi Arabia Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 38 Saudi Arabia Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 39 Saudi Arabia Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 40 Saudi Arabia Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 41 Saudi Arabia Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 42 Saudi Arabia Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 43 South Africa Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 44 South Africa Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 45 South Africa Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 46 South Africa Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 47 South Africa Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 48 South Africa Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 49 Nigeria Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 50 Nigeria Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 51 Nigeria Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 52 Nigeria Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 53 Nigeria Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 54 Nigeria Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 55 Rest of LAMEA Clinical Trials Matching Software Market, 2019 - 2022, USD Thousands
TABLE 56 Rest of LAMEA Clinical Trials Matching Software Market, 2023 - 2030, USD Thousands
TABLE 57 Rest of LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2022, USD Thousands
TABLE 58 Rest of LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2023 - 2030, USD Thousands
TABLE 59 Rest of LAMEA Clinical Trials Matching Software Market, by End-use, 2019 - 2022, USD Thousands
TABLE 60 Rest of LAMEA Clinical Trials Matching Software Market, by End-use, 2023 - 2030, USD Thousands
TABLE 61 Key Information – Clario
TABLE 62 Key Information – IBM Corporation
TABLE 63 Key Information – Antidote Technologies, Inc.
TABLE 64 Key Information – Ofni Systems Inc.
TABLE 65 Key Information – Advarra, Inc.
TABLE 66 Key Information – ArisGlobal LLC
TABLE 67 Key Information – Teckro, Inc.
TABLE 68 Key Information – BSI Business Systems Integration AG
TABLE 69 Key Information – Clinical Trials Mobile Application
TABLE 70 Key Information – Optimapharm d.o.o.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Clinical Trials Matching Software Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Clinical Trials Matching Software Market
FIG 4 Porter’s Five Force Analysis: Clinical Trials Matching Software Market
FIG 5 LAMEA Clinical Trials Matching Software Market share, by Deployment Mode, 2022
FIG 6 LAMEA Clinical Trials Matching Software Market share, by Deployment Mode, 2030
FIG 7 LAMEA Clinical Trials Matching Software Market, by Deployment Mode, 2019 - 2030, USD Thousands
FIG 8 LAMEA Clinical Trials Matching Software Market share, by End-use, 2022
FIG 9 LAMEA Clinical Trials Matching Software Market share, by End-use, 2030
FIG 10 LAMEA Clinical Trials Matching Software Market, by End-use, 2019- 2030, USD Thousands
FIG 11 LAMEA Clinical Trials Matching Software Market share, by Country, 2022
FIG 12 LAMEA Clinical Trials Matching Software Market share, by Country, 2030
FIG 13 LAMEA Clinical Trials Matching Software Market, by Country, 2019- 2030, USD Thousands
FIG 14 SWOT Analysis: Clario
FIG 15 SWOT Analysis: IBM Corporation
FIG 16 SWOT Analysis: Antidote Technologies, Inc.
FIG 17 SWOT Analysis: Ofni Systems Inc.
FIG 18 SWOT Analysis: Advarra, Inc.
FIG 19 SWOT Analysis: ArisGlobal LLC
FIG 20 SWOT Analysis: Teckro, Inc.
FIG 21 SWOT Analysis: BSI Business Systems Integration AG
FIG 22 SWOT Analysis: Clinical Trials Mobile Application
FIG 23 SWOT Analysis: Optimapharm d.o.o.

Purchase Full Report of
LAMEA Clinical Trials Matching Software Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL